PAMU
ARCT icon

Pictet Asset Management (UK)’s Arcturus Therapeutics ARCT Stock Holding History

Pictet Asset Management (UK)’s Portfolio ARCT Stock Details ARCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		$2.06M Buy
60,930
+42,168
+225% +$1.43M ﹤0.01% 1007
2021
Q1 		$775K Buy
+18,762
New +$1.12M ﹤0.01% 1100

Other funds holding ARCT

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Bank Julius Baer & Co
Bank Julius Baer & Co Zurich, Switzerland $38.6B AUM 35.31% 1-Year Est. Return

Pictet Asset Management (UK)'s ARCT Position: Q2 2021 in Review

Pictet Asset Management (UK) increased its Arcturus Therapeutics (ARCT) stake by 225% in Q2 2021, buying an estimated $1.43M and bringing the position to 60,930 shares worth $2.06M. The position accounts for ﹤0.01% of the portfolio, ranked #1007.

Pictet Asset Management (UK) first reported a position in ARCT in Q1 2021 and has held it in 2 quarters since. 139 funds tracked by Wall St. Rank hold ARCT as of Q2 2021.

  • Pictet Asset Management (UK) held 60,930 shares of Arcturus Therapeutics worth $2.06M as of Q2 2021.
  • Pictet Asset Management (UK) bought 42,168 Arcturus Therapeutics shares in Q2 2021, an estimated $1.43M.
  • Arcturus Therapeutics made up ﹤0.01% of Pictet Asset Management (UK)'s portfolio in Q2 2021, its #1007 holding.
  • Pictet Asset Management (UK) first reported a position in Arcturus Therapeutics in Q1 2021 and has held it in 2 quarters since.
  • 139 funds tracked by Wall St. Rank held Arcturus Therapeutics as of Q2 2021.

Based on Pictet Asset Management (UK)'s 13F filing for Q2 2021, filed 16 Aug 2021.